Search

everythinglearnresearchcommunity

for

Search:↓

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

EF and PXE not closely related.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Exo.Reset® uses extracellular vesicle technology for skin rejuvenation.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Estetrol may help prevent hair loss and support hair growth in women.

Estrogen helps improve skin aging and healing, especially in post-menopausal women.

MVP treatment is effective and safe for recurrent breast cancer.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Fat tissue vesicles protect skin from UV damage better than stem cell vesicles.

17b-Estradiol in skin affects hair growth and tumor promotion.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

Eflornithine HCl 13.9% cream is safe for skin use with mild, temporary irritation.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.